Demystifying Medicine Video



Approximately one out of four individuals are estimated to have latent mycobacterium tuberculosis (Mtb). This means that these individuals may develop an active form of the disease at any time and require antibiotic treatment. In this video, Ana Tomljenovic-Berube provides background information on tuberculosis. Dr. Tomljenovic-Berube is an assistant professor in the McMaster School of Interdisciplinary Sciences.


[Please complete our feedback form]



References
  • Campbell, E. A., Korzheva, N., Mustaev, A., Murakami, K., Nair, S., Goldfarb, A., & Darst, S. A. (2001). Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell, 104(6), 901-912.
  • Cope, G., & Cope, A. (2013). Antibiotic resistance and how to act on it. Dental Nursing, 9(12), 706-709.
  • Liu, H., Zhang, Q., An, X., Liu, H., Wang, S., & Xiao, T. (2019). Uncovering the Resistance Mechanism of Mycobacterium tuberculosis to Rifampicin Due to RNA Polymerase H451D/Y/R Mutations From Computational Perspective. Frontiers in Chemistry, 7, 819.
  • Public Health Agency of Canada. (2019). Tuberculosis (TB). (2018).
  • Government of Canada. Tuberculosis: Prevention and risks.
  • World Health Organization. Tuberculosis (TB). (2019).